Core Viewpoint - Dongbao Biological announced that it will not adjust the conversion price of its convertible bonds despite triggering conditions for a downward adjustment due to stock prices being below 90% of the conversion price for 15 trading days [1] Group 1: Company Actions - The company’s stock price has been below the conversion price of 6.63 yuan per share for 15 trading days, triggering the conditions for a downward adjustment of the "Dongbao Convertible Bonds" [1] - The board of directors held a meeting on October 15, 2025, and decided not to adjust the conversion price of the "Dongbao Convertible Bonds" [1] - From October 16, 2025, to April 15, 2026, if the conditions for a downward adjustment are triggered again, the company will not propose a downward adjustment plan [1] Group 2: Future Considerations - After April 16, 2026, if the conditions for a downward adjustment are triggered again, the board will convene to decide whether to exercise the right to adjust the conversion price [1]

Core Viewpoint - The article discusses the status of various convertible bonds, highlighting which bonds are subject to strong redemption, which are not, and providing details on their trading and conversion values [1][2]. Group 1: Convertible Bonds Status - Sheng 24 Convertible Bond is subject to strong redemption [1][2]. - Dongbao Convertible Bond, Zhengyuan Convertible Bond 02, and Yifeng Convertible Bond are not subject to adjustment [1][2]. - Huicheng Convertible Bond, Xinzhi Convertible Bond, and Tairui Convertible Bond are not subject to strong redemption [1][2]. Group 2: Trading and Conversion Details - The current price of Sanyang Convertible Bond is 126.154, with a strong redemption price of 100.490, and a conversion value of 127.38 [4]. - The current price of Zhongchen Convertible Bond is 135.377, with a strong redemption price of 100.580, and a conversion value of 135.93 [4]. - The current price of Jingxing Convertible Bond is 196.000, with a strong redemption price of 100.290, and a conversion value of 195.58 [4]. - The current price of PuFa Convertible Bond is 110.364, with a redemption price of 110.000, and a conversion value of 105.28 [6].

Group 1 - The company announced that from September 17, 2025, to September 30, 2025, its stock price has been below the current conversion price of 6.63 yuan per share for ten trading days, which is 90% of the conversion price [1] - This situation is expected to trigger the downward adjustment condition for the "Dongbao Convertible Bonds" conversion price [1] - If the conversion price adjustment condition is triggered, the company will follow the provisions of the "Prospectus" to timely fulfill subsequent review procedures and information disclosure obligations [1]

Core Points - The company Baotou Dongbao Biotechnology Co., Ltd. announced that from September 17 to September 30, 2025, its stock closing price has been below 90% of the current conversion price of 6.63 CNY per share for ten trading days, which is expected to trigger the downward adjustment condition for the "Dongbao Convertible Bonds" [1] - The total issuance amount of "Dongbao Convertible Bonds" is 455 million CNY, which was listed on August 18, 2023, with a conversion period from February 5, 2024, to July 30, 2029 [1] - If the adjustment condition is triggered, the company's board of directors has the authority to decide whether to propose an adjustment plan and submit it for shareholder meeting review, while fulfilling the necessary review procedures and information disclosure obligations [1]

Core Points - The company, Dongbao Biological Technology Co., Ltd., has announced the interest payment details for its convertible bonds, known as "Dongbao Convertible Bonds" [1][2] - The interest rate for the bonds is set at 0.50%, with specific interest payments of 5.00 RMB (including tax) for every ten bonds held [1][2] - The bonds were issued on July 31, 2023, with a total of 4,550,000 bonds available for investors [1] Interest Payment Details - The interest payment period is from July 31, 2024, to July 30, 2025, with interest paid annually [1][2] - The interest payment record date is set for July 30, 2025, and investors who sell the bonds before this date will not receive the interest payment [1][3] - The company will not pay interest for the current and future periods to bondholders who convert their bonds into company stock before the interest payment record date [1][4] Taxation Information - Individual bondholders are subject to a personal income tax rate of 20% on the interest earned, which will be withheld by the payment agent [4][5] - Foreign institutional investors are exempt from corporate income tax and value-added tax on the interest income from these bonds until December 31, 2025 [5]

Core Points - Dongbao Biological (300239) closed at 5.6 yuan on June 13, 2025, a 0.36% increase from the previous week's 5.58 yuan [1] - The company has a total market capitalization of 3.324 billion yuan, ranking 45th out of 50 in the bioproducts sector and 3972nd out of 5150 in the A-share market [1] Company Announcements - Dongbao Biological announced a cash dividend of 0.25 yuan per 10 shares (including tax) for the 2024 fiscal year, with the record date on June 16, 2025, and the ex-dividend date on June 17, 2025 [1][4] - The company will not issue new shares or use capital reserves for this dividend distribution, and the remaining undistributed profits will be carried forward to future distributions [1] - The adjusted cash dividend per 10 shares after the distribution will be approximately 0.245546 yuan (including tax) [1] Convertible Bond Adjustments - The conversion price for Dongbao Convertible Bonds (123214) will be adjusted from 6.65 yuan to 6.63 yuan per share, effective June 17, 2025 [2][4] - The company issued 455 million yuan worth of convertible bonds, with a total of 4.55 million bonds available for conversion [2] Share Buyback Adjustments - Following the 2024 dividend distribution, the maximum buyback price will be adjusted from 8.00 yuan to 7.98 yuan per share, with the expected buyback quantity adjusted to between 6,265,700 and 12,531,300 shares [3][4] - The buyback plan was approved on January 3, 2025, with a duration of 12 months [3]

Core Viewpoint - The company has announced a profit distribution plan for the fiscal year 2024, which includes a cash dividend of RMB 0.25 per 10 shares (tax included) to all shareholders, excluding shares held in the repurchase account [1][2][4]. Summary by Sections Profit Distribution Plan - The profit distribution plan was approved at the shareholders' meeting on May 15, 2025, with a cash dividend of RMB 0.25 per 10 shares (tax included) to all shareholders, without issuing bonus shares or capital reserve conversion [2][4]. - The total number of shares eligible for the dividend is calculated by deducting the repurchased shares from the total share capital as of the record date [3][4]. Dividend Calculation - The total cash dividend amount is adjusted based on the number of shares held after accounting for repurchased shares, resulting in a total cash dividend of RMB 14,575,863.32 (tax included) [3][4]. - The cash dividend per share is calculated as the total cash dividend divided by the adjusted total share capital, leading to a reference price adjustment for the ex-dividend date [6]. Key Dates - The record date for the dividend distribution is set for June 16, 2025, with the ex-dividend date on June 17, 2025 [5]. - Shareholders registered by the record date will receive the cash dividend directly into their accounts through their custodial securities companies [5]. Adjustments and Regulations - The company’s repurchased shares will not participate in this dividend distribution, and the conversion price of the company's convertible bonds will be adjusted accordingly [6].

Group 1 - The company has issued convertible bonds amounting to 455 million yuan, with a face value of 100 yuan per bond, totaling 4,550,000 bonds [1] - The initial conversion price for the convertible bonds was set at 6.67 yuan per share, which has been adjusted to 6.65 yuan per share effective from May 31, 2024 [2] - The adjusted conversion price after the latest cash dividend distribution is 6.63 yuan per share, effective from June 17, 2025 [4] Group 2 - The company will adjust the conversion price based on various corporate actions such as stock dividends, capital increases, and cash dividends, following specific formulas [1][2] - The company will disclose any adjustments to the conversion price through official announcements on the Shenzhen Stock Exchange or other designated media [2] - The company has a profit distribution plan for 2024, which does not include stock dividends or capital increases, and will carry forward undistributed profits to future distributions [3]

Core Viewpoint - The company announces a temporary suspension of the conversion of its convertible bonds, effective from June 9, 2025, until the equity registration date for the 2024 annual equity distribution, to ensure the smooth implementation of the distribution [1] Group 1: Convertible Bonds Information - The convertible bonds (code: 123214; name: Dongbao Convertible Bonds) will be suspended for conversion during the specified period but will continue to trade normally [1] - The company will adjust the conversion price of the bonds in the event of stock dividends, capital increases, new share issuances, rights issues, or cash dividends, following a specific formula [1][2] - The adjustment formulas for the conversion price are detailed, including variables for stock dividends, new share prices, and cash dividends [1] Group 2: Price Adjustment Procedures - The company will publish announcements regarding the adjustment of the conversion price on the Shenzhen Stock Exchange website or other designated media, including the adjustment date and method [2] - In cases of share buybacks, mergers, splits, or other events affecting share categories or quantities, the company will adjust the conversion price to protect the rights of bondholders [2]